When Rs 5 biscuits become too pricey for Indian workers

Agencies
August 26, 2019

Aug 26: When snack makers start to lament that Indians can’t afford to spend Rs 5 (7 cents) on biscuits, it’s time to stop arguing over how much of the nation’s slowdown is cyclical and what part is structural.

Considering its glaring income, wealth and consumption inequalities, India is a surprisingly calm society. However, when purchasing power dries up to the extent that rural laborers and urban blue-collar workers have to think twice about cheap munchies, then the situation is desperate. The culprit is deep-rooted wage suppression, a long-term issue that needs attention.

Britannia Industries, the number one biscuit maker, recently sounded the alarm bells over the sharp deceleration in its domestic sales volumes. Rival Parle Products chimed in and said jobs were at risk for as many as 10,000 of its workers.

A Parle executive put the blame on goods and services tax (GST). While the consumption tax may indeed have been an additional burden in an economy slowing under a disastrous November 2016 currency ban, the funk has its roots in insufficient wages.

In recent years, only about a third of the economy’s income has gone to labour, with providers of debt and equity capital taking the rest, according to India Ratings and Research. Raising that 33.2% labour share to the developing-country average of 37.4% would put an extra $100 billion of annual spending power in the hands of Indian households.

Only then can India start facing up to the tougher challenge of reaching advanced-economy levels. It has a long way to go. The labour share of income in the US was almost 57% in 2016, even after a near 10-percentage-point drop following World War II that was caused by technological changes and globalisation, according to McKinsey & Co.

Trouble is, the distribution of the Indian economic pie is more lopsided than the aggregate numbers suggest. As IndRa’s analysis shows, 80% of the output generated in informal production gets used up in paying for capital, which is scarce; households get only 20% in exchange for toiling on farms and in cottage industries. At the same time, only 32% of the production of a bloated public sector is shared with the taxpayers and banks that provide the capital; as much as 68% goes to a privileged group of state and quasi-state workers who enjoy assured jobs and higher pay than they would in the private sector.

The long-overdue privatisation of inefficient behemoths like Air India would reduce the wastage of capital in the public sector. But it won’t automatically help informal private businesses grow and become productive.

In its first term, the government of Prime Minister Narendra Modi thought taxation would provide the required nudge. It set out to formalize entire supply chains by bringing even small firms under the ambit of the GST. The poorly designed, badly implemented plan backfired.

Two years later, New Delhi is furious that it can’t meet revenue targets; its frustration is leading to an antagonistic stance toward firms. Meanwhile, industries from autos to biscuits are demanding lower GST rates. There’s no fiscal room to please all. The government hit the brakes on its own investments in the June quarter, amid an extended slump in private capital expenditure.

Taxes aren’t the solution. Easier hiring-and-firing norms – and not mere consolidation of archaic labour laws – will boost employment in more productive large firms that can pay better. If Amazon can build its largest global center in India, why should factories be afraid to scale up by hiring blue-collar workers? At the other end of the spectrum, small firms need finance.

A year-long liquidity crunch in shadow banking has caused jitters in India’s market for loans-against-property, which is how midsize businesses finance themselves. But even the luxury of a $25,000 loan obtained by mortgaging property worth $350,000 isn’t for everyone, as Pratibha Chhabra, a financial inclusion specialist at the World Bank, notes.

Most small firms only have inventory and invoices to pledge, and no lender wants to be left holding half-made chairs, or potatoes rotting in a warehouse.

However, if a bank lending to a furniture maker or a potato farmer in India can get repaid directly by Ikea or PepisCo against certified invoices, it can share the benefit of the final customer’s creditworthiness with the borrowers. This is how Citigroup Inc. greases the global supply chain of 700 multinationals and their 70,000 vendors. Since most tiny businesses run on household labour, only statisticians will worry about whether wages or profits are getting the lift. Spending power in the economy will rise.

Such financing is well established in developed markets, though in India “to efficiently finance small firms by locating them in larger supply chains will be the next frontier,” says Gaurav Arora, head of Asia Pacific at Greenwich Associates.

India is overdependent on Bangladesh’s model of microfinance, which uses group pressure and social shame to collect on exorbitantly priced – but collateral-free – small loans. The country is barking up the wrong tree. A woman doing embroidery on a sari will never get more than a fraction of what her craft will ultimately sell for. But she can be given access to cheap credit. Then, she’ll also be able to buy more biscuits for her children.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 2,2020

Bengaluru, May 2: Former chief minister and Congress leader Siddaramaiah have urged the state government to arrange free-transport facilities to those stranded labourers and their family members to return their native places.

In a statement issued here on Friday, the former chief minister criticised the State Government for having decided to collect bur fare from them, ''three-times more than the regular fare''.

Stating that the migrant labourers, who had been stranded ever since lockdown had been clamped in the entire country are not in a position to pay for their travel, Siddaramaiah urged the state government to treat them with human face.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Bengaluru, Mar 25: Bengaluru Police Commissioner Bhaskar Rao on Wednesday called a meeting of online, e-commerce food, medicine, groceries or animal products delivery aggregators at his office in wake of situation arising out of lockdown imposed in the entire country due to coronavirus epidemic.

The Police Commissioner has appealed one representative from each agency to join him in the meeting at 7 pm.

"I have called a meeting of online, e-commerce food, medicine, groceries, vegetables/fruits or animal products delivery aggregators today at 7 pm at my office at Infantry Road, Bengaluru," said Rao.

"One representative from each agency may please come. We promise all cooperation, please come," he said.
The Indian Council of Medical Research (ICMR) on Wednesday confirmed 539 positive cases of coronavirus in the country.

Prime Minister Narendra Modi had on Tuesday announced a 21-day lockdown in the entire country effective from midnight to deal with the spread of coronavirus, saying that "social distancing" is the only option to deal with the disease, which spreads rapidly.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 16,2020

University of Oxford researchers have claimed that a cheap and widely available drug called dexamethasone can help save the lives of patients who are seriously ill with coronavirus.

Scientists working on the Recovery Trial found the drug could help patients on ventilators and oxygen, but had no effect on those who did not need help breathing.

“Based on these results, one death would be prevented by treatment of around eight ventilated patients or around 25 patients requiring oxygen alone,” researchers said in a statement.

Matt Hancock, the health secretary, tweeted: “This global first exemplifies the power of science.”

“I’m absolutely delighted that today we can announce the first successful clinical trial for a treatment for Covid-19,” Mr Hancock said.

Recovery Trial experts said a randomised group of 2,104 patients was given 6mg of dexamethasone per day for 10 days, while another group of 4,321 were given normal treatment.

Dexamethasone reduced deaths by one-fifth in patients on oxygen feeds and by one-third in those who needed a ventilator to breathe, preliminary results showed.

Mr Hancock added: “This is a huge step forward and it’s because we’ve backed the science.”

Martin Landray, professor of medicine and epidemiology at the Nuffield Department of Population Health, University of Oxford, and one of the trial’s chief investigators, said in a statement: “These preliminary results from the Recovery Trial are very clear – dexamethasone reduces the risk of death among patients with severe respiratory complications.

“Covid-19 is a global disease – it is fantastic that the first treatment demonstrated to reduce mortality is one that is instantly available and affordable worldwide.”

Comments

kushal kumar
 - 
Thursday, 18 Jun 2020

Trials  of  drug  dexamethasone   in  Covid-19  cases   have  brought  success  in  saving  lives  ,  claim  Oxford  University  scientists  on  16 June  2020. 

              According  to  news  reports  on  16 June  , 2020  ,   Oxford  University  Scientists  have  conducted  trials  on  anti-inflammatory  steroid  Dexamethasone   in  Covid-19  cases.  Results  released  by  the   Oxford  University    on  16  June  2020  say  that  the   low-cost  and  easily  available  drug  saves  the  people  seriously  infected  by   Coronavirus  ,  cuts  the  death  risk  by  a  third  for  those  on  ventilators  and  by  a  fifth  for  those  on  oxygen.  The  commentary   on  the  drug   reads  like  this  :-

“  This  is  a  tremendous  news  today  from  the  recovery  trial  showing  that  dexamethasone   is  the  first  drug  to  reduce  mortality  from  Covid-19.  It  is  particularly  exciting  as  this  is  an  inexpensive  widely  available  medicine.  This  is  a  ground  breaking  development  in  our  fight  against  the  disease  and  the  speed  at  which  researchers  have  progressed  finding  an  effective  treatment  ,  is  truly  remarkable.  It  shows  importance  of  doing  high  quality  clinical  trials  and  basing  decisions  as  the  results  of  those  trials”. 

               Covid-19  has  taken  into  its  grip   the  entire  world  during  first  half  of  the  year  2020  ,  infecting   lacs  and  killing  also  lacs  of   its  patients.  In  the  absence  of  an  effective  drug  or  vaccine  ,  people  had  no  choice  other  than   to   look   up   to  the  heavens  or   scientists  to  come  with  some  cure.  And  the  drug  described  here  is  the  first  one  to  respond  to  the  prayer   of  the  global  community  ,  it  seems.     As  regards  a  vaccine  ,   only  few  are  claiming  that  it  can  come  by  the  end  of  the  present  year  2020.  Rather   ,  some  are  of  the  view  that  it  may  take  a  larger  part  of  the  year  2021  and   could   even  go    to  mid-2022.   Whatever  that  scenario  about  prospect  of  arrival  of  vaccine  to  treat  Covid-19  may  be   ,  the  news  that  was  broken   on  16  June  2020   by   the  Oxford  University   scientists   in  relation  to   drug  dexamethasone   would  have  sent  a  wave  of   strength  and  hope   among   people  world-wide.  And  this  Vedic  astrology  writer  was  spirited  for  another  reason  as   well   -  a  prediction  of   when  some  relief   by  way  of  drug  to  fight  Covid-19   may  appear  ,   having  come  accurate  in   the   claim  announced  by  Oxford  University   on  16 June  2020.  This  writer  had  ,   based   on  interpretation  and  application   of  Vedic  astrology  ,   contributed  in  early  April  ,  2020   an  opinion  piece     - “  Some  searchlight  on  way  out  of  Covid-19  presently  tormenting  mankind” -   to  a  number  of   newspapers.  It  was  also  contributed  on  11  April  ,  2020   using  the  ‘ comments’   column  of  article  -‘ Heard  Charles  took   Ayurveda  treatment-based  Ayush  drugs  for   Covid-19’  -   at   theprint.in/india/looking-at-evidence-based-ayush-medicines-to-treat-covid-19-minister-shripad-naik/393407/.   The  text  in  the  opinion  piece  related  to  the  claim  of  success  announced  by  Oxford  University  scientists  on  16 June  ,  2020  ,  reads  like  this  :- 

“  So  reading  in  between  the  lines  ,  it  can  be  said  that  some  effective  drug   or  remedy  can  arrive  by   mid   or  towards   the  last  week  of  June  2020   to   provide  some  relief  during  July  to  September  2020 ,  to  some  good  extent”.

The  point  this  writer  wants  to  share  with  readers  world-wide  is  that   yes  ,  a  drug   envisaged  in  the  aforesaid  prediction  has  appeared  on  the  horizon  in  the  claim  announcement  of  Oxord  University  scientists  on  16  June ,  2020. 

Bio  :-

 

Kushal  kumar  ,

202-GH28  ,  Mansarovar   Apartments  ,

Sector  20  ,  Panchkula-134116  ,  Haryana,

India.

Note  :-  This  writer’s    significant  predictive  work  covering   2020   about   the  U.S.  and  Italy

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.